Loading
Every cancer trial would have to publish a short, clear summary that patients can understand, within twelve months of results, in one public place.
The EU Clinical Trials Regulation requires lay summaries within 12 months of trial end, but compliance is incomplete, quality varies and there is no US equivalent. The proposal is a global requirement (via ICMJE, registries and funders) that every interventional oncology trial deposit a plain-language summary meeting a readability standard, machine-tagged to the trial record, translated into major languages, and hosted centrally with the structured results.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov.
Shares Misinformation and unproven therapies, Knowledge reaches practice too slowly.
Shares Misinformation and unproven therapies, Knowledge reaches practice too slowly.
Shares Patients lack understanding, navigation and agency, Knowledge reaches practice too slowly.
Shares Misinformation and unproven therapies, Knowledge reaches practice too slowly.